Guo Da-Chuan, Chen Zhi-Teng, Wang Xiang, Gao Jing-Wei, Gao Qing-Yuan, Huang Ze-Gui, Chen Yang-Xin, Liu Pin-Ming, Wang Jing-Feng, Zhang Hai-Feng
Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China; Graduate School, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Can J Cardiol. 2025 Jan;41(1):114-123. doi: 10.1016/j.cjca.2024.07.007. Epub 2024 Jul 14.
Ideal cardiovascular health (CVH) has been associated with reduced cardiovascular disease risk and mortality, but its association with cardiac arrhythmias was still unsettled. In this prospective cohort study, we investigated the relationship between CVH and subsequent arrhythmias risk, including atrial fibrillation (AF)/flutter, ventricular arrhythmias, and bradyarrhythmias.
Data from 287,264 participants initially free of arrhythmias in the UK Biobank were included in the analysis. Cox regression models were used to examine the relationship between CVH levels calculated by the American Heart Association's Life's Essential 8 (LE8) metrics, with cardiac arrhythmias risk.
During a median follow-up period of 12.8 years, 16,802 incident AF, 2186 incident ventricular arrhythmias, and 4128 incident bradyarrhythmias were identified. After adjustment for confounding factors, participants with high initial CVH levels had significantly lower risks for AF (hazard ratio [HR], 0.63; 95% confidence interval [CI], 0.59-0.68), ventricular arrhythmias (HR, 0.48; 95% CI, 0.40-0.59), and bradyarrhythmias (HR, 0.64; 95% CI, 0.55-0.74) compared with those with low CVH levels. Furthermore, each standard deviation (SD) increase in LE8 scores was associated with a 15% lower risk of AF, 21% for ventricular arrhythmias, and 13% for bradyarrhythmias, respectively. In addition, a significant interaction was observed between CVH levels and the genetic risk of AF (P for interaction, 0.021). The reverse correlation seemed to be more noticeable in individuals with a lower genetic susceptibility to AF.
We concluded that higher levels of CVH, estimated by the LE8 metrics, were associated with significantly reduced risks of AF, ventricular arrhythmias, and bradyarrhythmias.
理想的心血管健康(CVH)与降低心血管疾病风险和死亡率相关,但其与心律失常的关联仍未明确。在这项前瞻性队列研究中,我们调查了CVH与后续心律失常风险之间的关系,包括心房颤动(AF)/心房扑动、室性心律失常和缓慢性心律失常。
分析纳入了英国生物银行中287,264名最初无心律失常的参与者的数据。采用Cox回归模型来检验由美国心脏协会的生命基本8项(LE8)指标计算得出的CVH水平与心律失常风险之间的关系。
在中位随访期12.8年期间,共识别出16,802例新发AF、2186例新发室性心律失常和4128例新发缓慢性心律失常。在调整混杂因素后,初始CVH水平高的参与者发生AF(风险比[HR],0.63;95%置信区间[CI],0.59 - 0.68)、室性心律失常(HR,0.48;95%CI,0.40 - 0.59)和缓慢性心律失常(HR,0.64;95%CI,0.55 - 0.74)的风险显著低于CVH水平低的参与者。此外,LE8评分每增加一个标准差(SD),发生AF的风险分别降低15%,室性心律失常降低21%,缓慢性心律失常降低13%。此外,还观察到CVH水平与AF的遗传风险之间存在显著交互作用(交互作用P值为0.021)。在对AF遗传易感性较低的个体中,这种负相关似乎更为明显。
我们得出结论,由LE8指标评估的较高CVH水平与AF、室性心律失常和缓慢性心律失常风险的显著降低相关。